The neuromuscular effects of rocuronium under sevoflurane-remifentanil or propofol-remifentanil anesthesia: a randomized clinical comparative study in an Asian population

摘要

Background We conducted a prospective, randomized, multicenter study to evaluate the differences in the blocking effect of different doses of rocuronium between sevoflurane- or propofol-remifentanil anesthesia in an Asian population. Methods A total of 368 ASA I–II patients was enrolled. Anesthesia was induced with 2.0?mg/kg propofol and 0.1?μg/kg/min remifentanil (TIVA) or 5.0?vol.% sevoflurane with 0.1?μg/kg/min remifentanil (SEVO). Tracheal intubation was facilitated at 180?s after the administration of rocuronium at 0.3, 0.6, or 0.9?mg/kg and then intubation condition was evaluated. The time to maximum block and recovery profile were monitored by TOF stimulation of the ulnar nerve and by recording the adductor pollicis response using acceleromyography. Results The numbers of patients with clinically acceptable intubation conditions were 41, 82, and 97?% (TIVA) and 34, 85, and 90?% (SEVO) at each dose of rocuronium, respectively. There were no significant differences in the time to maximum block between groups at each rocuronium dose. There were significant differences in the recovery to a train-of-four ratio of 90?% between the groups: 42.7 (19.5), 74.8 (29.9), and 118.4 (35.1) min (TIVA) and 66.5 (39.3), 110.2 (43.5), and 144.4 (57.5) min (SEVO) at 0.3, 0.6, and 0.9?mg/kg, respectively ( P Conclusions There are no significant differences in intubation conditions between propofol-remifentanil and sevoflurane-remifentanil anesthesia at the same dose of rocuronium. The type of anesthetic does not significantly influence the time to maximum block by rocuronium. Rocuronium at a dose of 0.9?mg/kg should be used for better intubation conditions with both anesthesia regimens in an Asian population. Trial registration UMIN-CTR Clinical Trial ( http://www.umin.ac.jp/ctr/index.htm ; UMIN#000007289 ; date of registration 14th February 2012).